Pictet Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Sell |
235,920
-10,166
| -4% | -$483K | 0.01% | 628 |
|
|
2025
Q1 | $9.07M | Sell |
246,086
-26,618
| -10% | -$981K | 0.01% | 685 |
|
|
2024
Q4 | $10.7M | Buy |
272,704
+22,414
| +9% | +$882K | 0.01% | 648 |
|
|
2024
Q3 | $11.8M | Buy |
250,290
+59,882
| +31% | +$2.83M | 0.01% | 609 |
|
|
2024
Q2 | $10.3M | Sell |
190,408
-130,115
| -41% | -$7.03M | 0.01% | 621 |
|
|
2024
Q1 | $22.2M | Buy |
320,523
+311,849
| +3,595% | +$21.6M | 0.02% | 475 |
|
|
2023
Q4 | $543K | Hold |
8,674
| – | – | ﹤0.01% | 1224 |
|
|
2023
Q3 | $394K | Buy |
+8,674
| New | +$394K | ﹤0.01% | 1339 |
|